University of Calgary
Visiting professor, Canadian Centre for Health Economics
As a Canada Research Chair, Health Services and Systems Research, Dr Marshall focuses her research program on methods to improve the effectiveness and efficiency of health care services. This includes measurement of patient preferences, cost-effectiveness analysis, and dynamic simulation systems modeling of health care delivery. She is a founding co-investigator of the innovative Patient and Community Engagement Research (PaCER) Program at the University of Calgary which trains patients to design and conduct health research, using specific adapted methods of qualitative inquiry.
She holds a faculty appointment as a Professor at the University of Calgary (Department of Community Health Sciences and Department of Medicine) and also holds the Arthur J.E. Child Chair of Rheumatology Outcomes Research in the McCaig Institute of Bone and Joint Health. She is the Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute, a Senior Scientist of the Arthritis Research Canada, and a member of the O’Brien Institute of Public Health. Dr Marshall is the recipient of the Distinguished Achievement Cochrane Award for Research recognizing her outstanding success in research grants, publications and student mentorship, and the Award for Early Career Excellence in Graduate Education from the University of Calgary.
Dr. Marshall’s academic training includes a PhD from the School of Public Health at the University of North Carolina, Chapel Hill as an Alberta Heritage Foundation for Medical Research Scholar, an MSc in Health Services Research (University of Alberta) and a BSc in Biochemistry (University of Toronto).
She has experience in government (national technology assessment agencies in Canada and Sweden), academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe. She was previously Vice President, Global Health Economics and Outcomes Research at i3 Innovus, managing health economic projects globally for diagnostic and pharmaceutical products.
Dr. Marshall's research program, funded through grants from the Canadian Institutes for Health Research, Genome Canada, United States National Institute of Health (NIH), the Canadian Arthritis Society, and the Ontario Institute for Cancer Research is focused on measuring preferences using conjoint analysis, personalized medicine, cost-effectiveness analysis and health system modeling. She was the Project Lead for a NIH Program Grant on Translational and Policy Research in Personalized Medicine, which develops evidence to assess how personalized medicine can improve health outcomes.
Dr. Marshall is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as the Past President of the Board of Directors, the Chair of the Dynamic Simulation Modeling Applications in Health Care Delivery Research Task Force and as a member of the Patient Preferences Special Interest Group and co-author of related ISPOR Task Force Reports. She led the development of the Guidelines on Budget Impact Analysis for the Canadian Patented Medicine Prices Review Board. She also serves on the Board of Directors for Health Technology Assessment International (HTAi) and the Editorial Boards of the International Journal for Technology Assessment in Health Care and The Patient.